FK 506: a novel immunosuppressant for treatment of autoimmune disease
- 1 April 1993
- journal article
- research article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 14 (4) , 323-344
- https://doi.org/10.1007/bf00192307
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mechanisms of tissue destruction and cellular activation in rheumatoid arthritisCurrent Opinion in Rheumatology, 1992
- The forces driving autoimmune diseaseJournal of Autoimmunity, 1992
- The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.1992
- An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in ratsClinical Immunology and Immunopathology, 1992
- Soluble IL-2 receptor in patients with primary nephrotic syndrome.1991
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings.1990
- EFFECTS OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON EXPERIMENTAL AUTOIMMUNE UVEORETINITIS IN RATS1988
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987